Evaluation of the Utility of the Edmonton Symptom Assessment System (revised) Scale on a Tertiary Palliative Care Unit

Beddard-Huber, Elizabeth; Jayaraman, Jyothi; White, Laura; Yeomans, Wendy

doi:10.1177/082585971503100107

Cited by 3 publications

(2 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Symptoms were measured using the Edmonton Symptom Assessment System (revised version) (ESAS-r) Scale [ 20 ]. The ESAS-r is a patient-reported instrument for patients near the end of life and is mostly used for monitoring symptoms in palliative care and hospices, but has also been used for monitoring symptoms in long-term care facilities [ 44 , 45 , 46 , 47 ] and to guide changes in the treatment of frail elderly patients [ 48 ]. The ESAS-r is based on a short numerical symptom scoring framework to enable quantitative measurements of symptoms with minimal patient burden [ 45 , 49 ].…”

Section: Methodsmentioning

confidence: 99%

“…The ESAS-r is a patient-reported instrument for patients near the end of life and is mostly used for monitoring symptoms in palliative care and hospices, but has also been used for monitoring symptoms in long-term care facilities [ 44 , 45 , 46 , 47 ] and to guide changes in the treatment of frail elderly patients [ 48 ]. The ESAS-r is based on a short numerical symptom scoring framework to enable quantitative measurements of symptoms with minimal patient burden [ 45 , 49 ]. The ESAS-r measures the intensity of each of eight symptoms (pain, tiredness, loss of appetite, nausea, depression, drowsiness, anxiety, and shortness of breath) using a numerical scale from 0 (no symptoms) to 10 (worst intensity of symptoms).…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Exploration of Symptom Scale as an Outcome for Deprescribing: A Medication Review Study in Nursing Homes

et al. 2022

View full text Add to dashboard Cite

The use of inappropriate medication is an increasing problem among the elderly, leading to hospitalizations, mortality, adverse effects, and lower quality of life (QoL). Deprescribing interventions (e.g., medication reviews (MRs)) have been examined as a possible remedy for this problem. In order to be able to evaluate the potential benefits and harms of a deprescribing intervention, quality of life (QoL) has increasingly been used as an outcome. The sensitivity of QoL measurements may, however, not be sufficient to detect a change in specific disease symptoms, e.g., a flair-up in symptoms or relief of side effects after deprescribing. Using symptom assessments as an outcome, we might be able to identify and evaluate the adverse effects of overmedication and deprescribing alike. The objective of this study was to explore whether symptom assessment is a feasible and valuable method of evaluating outcomes of MRs among the elderly in nursing homes. To the best of our knowledge, this has not been investigated before. We performed a feasibility study based on an experimental design and conducted MRs for elderly patients in nursing homes. Their symptoms were registered at baseline and at a follow-up 3 months after performing the MR. In total, 86 patients, corresponding to 68% of the included patients, received the MR and completed the symptom questionnaires as well as the QoL measurements at baseline and follow-up, respectively. Forty-eight of these patients had at least one deprescribing recommendation implemented. Overall, a tendency towards the improvement of most symptoms was seen after deprescribing, which correlated with the tendencies observed for the QoL measurements. Remarkably, deprescribing did not cause a deterioration of symptoms or QoL, which might otherwise be expected for patients of this age group, of whom the health is often rapidly declining. In conclusion, it was found that symptom assessments were feasible among nursing home residents and resulted in additional relevant information about the potential benefits and harms of deprescribing. It is thus recommended to further explore the use of symptom assessment as an outcome of deprescribing interventions, e.g., in a controlled trial.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Exploration of Symptom Scale as an Outcome for Deprescribing: A Medication Review Study in Nursing Homes

et al. 2022

View full text Add to dashboard Cite

show abstract

Divergent Perspectives on the Use of the Edmonton Symptom Assessment System (Revised) in Palliative Care

Schick‐Makaroff

Sawatzky

2019

J Hosp Palliat Nurs

View full text Add to dashboard Cite

The Edmonton Symptom Assessment System (Revised) (ESAS-r) contains 9 questions pertaining to symptoms/well-being. It is a standardized patient-reported assessment instrument, but inconsistently used in palliative care. Thus, a problem exists in knowledge translation regarding routine use of the ESAS-r in palliative practice. The objective was to understand clinicians' perspectives on the use of the ESAS-r in palliative care in hospitals and at home. Qualitative focus groups (n = 14 with 46 clinicians) and interviews (n = 24) elicited views regarding use of the ESAS-r in palliative practice. Interpretive description was used as a general approach to this qualitative analysis focused on understanding clinicians' views. Palliative clinicians presented multiple perspectives of the ESAS-r pertaining to their (1) underlying values, (2) disparate purposes, and (3) incommensurate responses toward use in daily practice. Benefits and challenges supported diversity within these themes, highlighting divergence among perspectives and complexity of integrating a standardized tool in patient care. Integration of the ESAS-r in palliative care requires (1) educational support for developing competence; (2) consideration of clinicians' existing, heterogeneous beliefs regarding the use of standardized assessment instruments; and (3) Consultation with multidisciplinary practitioners about optimal ways that ESAS-r results can be used in a person-centered approach to palliative care.

show abstract

Tangible Interactions for Pain Assessment in Palliative Care

Løkeland,

Guribye,

Stensvold

et al. 2024

Nordic Conference on Human-Computer Interaction

View full text Add to dashboard Cite

Evaluation of the Utility of the Edmonton Symptom Assessment System (revised) Scale on a Tertiary Palliative Care Unit

Abstract: Patient acuity, team expertise, perceived burden to patients, and time commitment all influenced staff's recommendation not to implement the ESAS-r tool on the palliative care unit.

Cited by 3 publications

References 16 publications

Exploration of Symptom Scale as an Outcome for Deprescribing: A Medication Review Study in Nursing Homes

Exploration of Symptom Scale as an Outcome for Deprescribing: A Medication Review Study in Nursing Homes

Divergent Perspectives on the Use of the Edmonton Symptom Assessment System (Revised) in Palliative Care

Tangible Interactions for Pain Assessment in Palliative Care

Contact Info

Product

Resources

About